M&A Deal Summary

Eurocept Acquires Medizorg Holding BV

On August 22, 2014, Eurocept acquired healthcare services company Medizorg Holding BV

Acquisition Highlights
  • This is Eurocept’s 1st transaction in the Healthcare Services sector.
  • This is Eurocept’s 1st transaction in the Netherlands.

M&A Deal Summary

Date 2014-08-22
Target Medizorg Holding BV
Sector Healthcare Services
Buyer(s) Eurocept
Deal Type Add-on Acquisition

Target

Medizorg Holding BV

Houten, Netherlands
Medizorg Holding BV has developed into a major medical homecare services agency. Medizorg provides patients who have been discharged from hospital but still require in-home nursing with the care they need. The company is headquartered in Houten, the Netherlands, operates all over the country with highly trained nurses, and provides logistics services and products which are delivered directly to patients' homes under the hospital's supervision.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Eurocept

Houten, Netherlands

Category Company
Founded 2001
Sector Life Science
DESCRIPTION

Eurocept is a healthcare company offering a unique combination of specialty pharma and medical homecare. Eurocept Pharmaceuticals is responsible for the registration, marketing, distribution and sale of speciality medicines in the fields of anesthetics, psychiatry, urology, pediatrics and infectious diseases. Eurocept Homecare provides medical specialist homecare and related out-patient medical technology for medicine and food administration. Eurocept was founded in 2001 and is based in Houten, Netherlands.


DEAL STATS #
Overall 2 of 2
Sector: Healthcare Services M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
Country: Netherlands M&A 1 of 1
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-05 NordMedica A/S

Copenhagen K, Denmark

NordMedica A/S holds the worldwide licence for the product Amsidine, currently marketed under the trademarks Amekrin®, Amsidine® and Amsidyl®. Amsidine is a chemotherapeutic drug with the active ingredient Amsacrine. It has a solid reputation and is used for the treatment of Acute Myeloid Leukaemia (AML) and Acute Lymphatic Leukaemia (ALL).

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-20 Da Vinci Kliniek

Geldrop, Netherlands

Da Vinci Kliniek provides patients with poorly healing (chronic) wounds, skin breakdown (bedsores), skin and tissue damage after radiation treatment more successful, faster, and more effective treatment than currently possible. Da Vinci Kliniek combines state-of-the-art treatment methods combined with an integrated care concept. The clinic combines her care through multidisciplinary working, by a team of qualified medical specialists, with specialized home care, in a chain.

Sell -